Research discovery

Find the original research

Live search across PubMed, the U.S. National Library of Medicine's citation database, and ClinicalTrials.gov. We show what each record is and link you to it; we don't summarise findings or rank studies by what they conclude.

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Find the original research

A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer (opens ClinicalTrials.gov)

Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors (opens ClinicalTrials.gov)

Volrustomig Priming Regimens Exploratory Phase II Platform Study (opens ClinicalTrials.gov)

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006) (opens ClinicalTrials.gov)

A Study of COVID-19 Vaccine(s) in Children and Adults (opens ClinicalTrials.gov)

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors (opens ClinicalTrials.gov)

Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm (opens ClinicalTrials.gov)

Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast Cancer (opens ClinicalTrials.gov)

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease (opens ClinicalTrials.gov)

Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas (opens ClinicalTrials.gov)

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (opens ClinicalTrials.gov)

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma (opens ClinicalTrials.gov)

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors (opens ClinicalTrials.gov)

Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma (opens ClinicalTrials.gov)

HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC (opens ClinicalTrials.gov)

EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer (opens ClinicalTrials.gov)

DPX-Survivac and Checkpoint Inhibitor in DLBCL (opens ClinicalTrials.gov)

Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy (opens ClinicalTrials.gov)

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial (opens ClinicalTrials.gov)

A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02) (opens ClinicalTrials.gov)